These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 2176354)

  • 1. Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells.
    Rauth S; Hoganson GE; Davidson RL
    Somat Cell Mol Genet; 1990 Nov; 16(6):583-92. PubMed ID: 2176354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
    Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of tyrosinase mRNA levels in melanoma cells by tumor promoters and by insulin.
    Fuller BB; Niekrasz I; Hoganson GE
    Mol Cell Endocrinol; 1990 Aug; 72(2):81-7. PubMed ID: 1704321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene.
    Rauth S; Davidson RL
    Somat Cell Mol Genet; 1993 May; 19(3):285-93. PubMed ID: 8332936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
    Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of tyrosinase mRNA in mouse melanoma cells by alpha-melanocyte-stimulating hormone.
    Rungta D; Corn TD; Fuller BB
    J Invest Dermatol; 1996 Nov; 107(5):689-93. PubMed ID: 8875950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
    Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
    Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanotropic activity of gamma MSH peptides in melanoma cells.
    Slominski A; Costantino R; Wortsman J; Paus R; Ling N
    Life Sci; 1992; 50(15):1103-8. PubMed ID: 1556905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells.
    Kosano H; Setogawa T; Kobayashi K; Nishigori H
    Life Sci; 1995; 56(20):1707-13. PubMed ID: 7723599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
    Slominski A; Moellmann G; Kuklinska E
    J Cell Sci; 1989 Apr; 92 ( Pt 4)():551-9. PubMed ID: 2557357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the regulation of pigmentation in alpha-melanocyte-stimulating hormone responsive and unresponsive cultured B16 melanoma cells.
    Hill SE; Buffey J; Thody AJ; Oliver I; Bleehen SS; Mac Neil S
    Pigment Cell Res; 1989; 2(3):161-6. PubMed ID: 2549531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cAMP-dependent protein kinase is required for optimal alpha-melanocyte-stimulating hormone-induced pigmentation.
    Ao Y; Park HY; Olaizola-Horn S; Gilchrest BA
    Exp Cell Res; 1998 Oct; 244(1):117-24. PubMed ID: 9770355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tyrosinase activity and protein synthesis in melanoma cells by calcium ionophore A23187.
    Fuller BB
    Pigment Cell Res; 1987; 1(3):176-80. PubMed ID: 2854256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB; Lebowitz J
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
    Bertolotto C; Bille K; Ortonne JP; Ballotti R
    J Cell Biol; 1996 Aug; 134(3):747-55. PubMed ID: 8707852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
    Wrathall JR; Oliver C; Silagi S; Essner E
    J Cell Biol; 1973 May; 57(2):406-23. PubMed ID: 4633171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine responsiveness in human melanocytes and melanoma cells in culture.
    Fuller BB; Meyskens FL
    J Natl Cancer Inst; 1981 May; 66(5):799-802. PubMed ID: 6262556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
    Sato K; Toriyama M
    J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of alpha-melanocyte-stimulating hormone, melatonin, cyclic AMP and cyclic GMP in the control of melanogenesis in hair follicle melanocytes in vitro.
    Weatherhead B; Logan A
    J Endocrinol; 1981 Jul; 90(1):89-96. PubMed ID: 6267154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thymidine analogs on tyrosinase activity and mRNA accumulation in mouse melanoma cells.
    Kidson SH; De Haan JB
    Exp Cell Res; 1990 May; 188(1):36-41. PubMed ID: 2139417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.